Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
People
Adjust height of sidebar
KMap
Profile
Gina Schwartzberg
Program Director, Arthritis / Musculoskeletal Diseases
College of Medicine - Tucson
Overview
Research
More
Collaboration
(6)
Muhammad Husnain
Mutual work: 1 Grant﹒1 Proposal
Collaboration Details
Kirsten Anderson
Mutual work: 4 Grants﹒6 Proposals
Collaboration Details
Gustavo Cornejo
Mutual work: 6 Proposals﹒3 Grants
Collaboration Details
Jazmin Dagnino
Mutual work: 3 Proposals﹒2 Grants﹒1 Supervisor
Collaboration Details
Carlos Tafich Rios
Mutual work: 3 Proposals﹒2 Grants
Collaboration Details
Page 1 of 2
Previous page
Next page
Grants
(4)
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)
Active
·
2024
·
$0 / $277.3K
·
External
systemic lupus erythematosus,
immunology,
clinical trials,
efficacy,
safety
A Phase 1 Study to Evaluate the Efficacy and Safety Of AB-101, an Allogeneic Cord Blood Derived NK-Cell Therapy in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III
Active
·
2024
·
$0 / $141.8K
·
External
cell therapy,
immunotherapy,
cancer treatment,
clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subject
Active
·
2023
·
$0 / $138.2K
·
External
pharmacokinetics,
efficacy,
safety,
tolerability,
pharmacodynamics
A 16-week Randomized Evaluation of the Impact of Mind.Px Application on Response to Biologic Treatment in Patients Suffering from Plaque Psoriasis Through Clinical Utility and Health Outcomes. (MATCH
Active
·
2022
·
$0 / $82K
·
External
digital health,
clinical trial,
biologic treatment,
psoriasis,
patient outcome
